These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31336074)

  • 1. Fetal cardiac remodeling and dysfunction is associated with both preeclampsia and fetal growth restriction.
    Youssef L; Miranda J; Paules C; Garcia-Otero L; Vellvé K; Kalapotharakos G; Sepulveda-Martinez A; Crovetto F; Gomez O; Gratacós E; Crispi F
    Am J Obstet Gynecol; 2020 Jan; 222(1):79.e1-79.e9. PubMed ID: 31336074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal hemodynamic profile during pregnancy and in the post-partum in hypertensive disorders of pregnancy and fetal growth restriction.
    Di Martino DD; Stampalija T; Zullino S; Fusè F; Garbin M; Parasiliti M; Sterpi V; Farina A; Ferrazzi E
    Am J Obstet Gynecol MFM; 2023 Mar; 5(3):100841. PubMed ID: 36563878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cord Blood Biomarkers of Cardiac Dysfunction and Damage in Term Growth-Restricted Fetuses Classified by Severity Criteria.
    Perez-Cruz M; Crispi F; Fernández MT; Parra JA; Valls A; Gomez Roig MD; Gratacós E
    Fetal Diagn Ther; 2018; 44(4):271-276. PubMed ID: 29190628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal cardiovascular impairment in pregnancies complicated by severe fetal growth restriction.
    Melchiorre K; Sutherland GR; Liberati M; Thilaganathan B
    Hypertension; 2012 Aug; 60(2):437-43. PubMed ID: 22733460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal myocardial dysfunction after normotensive fetal growth restriction compared with hypertensive pregnancies: a speckle-tracking study.
    Orabona R; Mohseni Z; Sciatti E; Mulder EG; Prefumo F; Lorusso R; Frusca T; Ghossein-Doha C; Spaanderman MEA
    J Hypertens; 2020 Oct; 38(10):1955-1963. PubMed ID: 32890271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Velocity vector imaging echocardiography and NT-proBNP study of fetal cardiac function in pregnancy-induced maternal hypertension.
    Yu L; Zhou Q; Peng Q; Zeng S; Yang Z
    J Clin Ultrasound; 2019 Jun; 47(5):285-291. PubMed ID: 30883813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paired maternal and fetal cardiac functional measurements in women with gestational diabetes mellitus at 35-36 weeks' gestation.
    Aguilera J; Semmler J; Coronel C; Georgiopoulos G; Simpson J; Nicolaides KH; Charakida M
    Am J Obstet Gynecol; 2020 Oct; 223(4):574.e1-574.e15. PubMed ID: 32335051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal cardiovascular hemodynamics in type 1 diabetic pregnancies at near-term gestation.
    Lehtoranta L; Haapsamo M; Vuolteenaho O; Palo P; Ekholm E; Räsänen J
    Acta Obstet Gynecol Scand; 2021 Feb; 100(2):263-271. PubMed ID: 32880890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does pre-eclampsia influence fetal cardiovascular function in early-onset intrauterine growth restriction?
    Crispi F; Comas M; Hernández-Andrade E; Eixarch E; Gómez O; Figueras F; Gratacós E
    Ultrasound Obstet Gynecol; 2009 Dec; 34(6):660-5. PubMed ID: 19827117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal changes in cardiac geometry and function in growth-restricted fetuses at term.
    Patey O; Carvalho JS; Thilaganathan B
    Ultrasound Obstet Gynecol; 2019 May; 53(5):655-662. PubMed ID: 30084123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal neurosonography at 31-35 weeks reveals altered cortical development in pre-eclampsia with and without small-for-gestational-age fetus.
    Basso A; Youssef L; Nakaki A; Paules C; Miranda J; Casu G; Salazar L; Gratacos E; Eixarch E; Crispi F; Crovetto F
    Ultrasound Obstet Gynecol; 2022 Jun; 59(6):737-746. PubMed ID: 35015926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal cardiac remodeling in twin pregnancy conceived by assisted reproductive technology.
    Valenzuela-Alcaraz B; Cruz-Lemini M; Rodríguez-López M; Goncé A; García-Otero L; Ayuso H; Sitges M; Bijnens B; Balasch J; Gratacós E; Crispi F
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):94-100. PubMed ID: 28508519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoglin in pregnancy complicated by fetal intrauterine growth restriction in normotensive and preeclamptic pregnant women: a comparison between preeclamptic patients with appropriate-for-gestational-age weight infants and healthy pregnant women.
    Laskowska M; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2012 Jun; 25(6):806-11. PubMed ID: 21793708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and late preeclampsia are characterized by high cardiac output, but in the presence of fetal growth restriction, cardiac output is low: insights from a prospective study.
    Tay J; Foo L; Masini G; Bennett PR; McEniery CM; Wilkinson IB; Lees CC
    Am J Obstet Gynecol; 2018 May; 218(5):517.e1-517.e12. PubMed ID: 29474844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of Cardiac Remodeling in Preadolescents With Fetal Growth Restriction.
    Sarvari SI; Rodriguez-Lopez M; Nuñez-Garcia M; Sitges M; Sepulveda-Martinez A; Camara O; Butakoff C; Gratacos E; Bijnens B; Crispi F
    Circ Cardiovasc Imaging; 2017 Jan; 10(1):. PubMed ID: 28093413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of assisted reproductive technology and small-for-gestational age on fetal cardiac remodeling.
    Valenzuela-Alcaraz B; Crispi F; Cruz-Lemini M; Bijnens B; García-Otero L; Sitges M; Balasch J; Gratacós E
    Ultrasound Obstet Gynecol; 2017 Jul; 50(1):63-70. PubMed ID: 27420642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between maternal hemodynamics and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia and fetal growth restriction.
    Giannubilo SR; Pasculli A; Tidu E; Biagini A; Boscarato V; Ciavattini A
    J Perinatol; 2017 May; 37(5):484-487. PubMed ID: 28151494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal cardiovascular remodeling persists at 6 months in infants with intrauterine growth restriction.
    Cruz-Lemini M; Crispi F; Valenzuela-Alcaraz B; Figueras F; Sitges M; Bijnens B; Gratacós E
    Ultrasound Obstet Gynecol; 2016 Sep; 48(3):349-56. PubMed ID: 26415719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placental transcriptional and histologic subtypes of normotensive fetal growth restriction are comparable to preeclampsia.
    Gibbs I; Leavey K; Benton SJ; Grynspan D; Bainbridge SA; Cox BJ
    Am J Obstet Gynecol; 2019 Jan; 220(1):110.e1-110.e21. PubMed ID: 30312585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?
    Villar J; Carroli G; Wojdyla D; Abalos E; Giordano D; Ba'aqeel H; Farnot U; Bergsjø P; Bakketeig L; Lumbiganon P; Campodónico L; Al-Mazrou Y; Lindheimer M; Kramer M;
    Am J Obstet Gynecol; 2006 Apr; 194(4):921-31. PubMed ID: 16580277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.